National Network Genomic Medicine Lung Cancer, Germany

RecruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
OTHER

observational, non-interventional

observational, non-interventional

Trial Locations (1)

Unknown

RECRUITING

University Hospital Cologne, Cologne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Helios Klinikum Emil von Behring

UNKNOWN

collaborator

Vivantes Hospital Berlin Neukölln

UNKNOWN

collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

University Hospital Erlangen

OTHER

collaborator

University Hospital, Essen

OTHER

collaborator

Goethe University

OTHER

collaborator

University Hospital Freiburg

OTHER

collaborator

University Hospital Giessen and Marburg

UNKNOWN

collaborator

University Hospital Halle (Saale)

UNKNOWN

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Klinikum Hanover-Siloah Hospital

OTHER

collaborator

University Hospital, Bonn

OTHER

collaborator

University Hospital Schleswig-Holstein

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

University Hospital Munich (LMU)

UNKNOWN

collaborator

University Hospital rechts der Isar Munich (TUM)

UNKNOWN

collaborator

Pius-Hospital Oldenburg

OTHER

collaborator

University Hospital Regensburg

OTHER

collaborator

University Hospital Tuebingen

OTHER

collaborator

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

OTHER

collaborator

University Hospital Ulm

OTHER

collaborator

Wuerzburg University Hospital

OTHER

collaborator

University Hospital of Cologne

OTHER

lead

Prof. Dr. Juergen Wolf

OTHER